A placebo-controlled, randomized, double-blind, MRI trial of antiherpes therapy in patients with relapsing-remitting multiple sclerosis (RRMS)

被引：0
|
作者：
Jakobsen, J
Bech, E
Gadeberg, P
Hansen, HJ
Christensen, T
Haahr, S
Hollsberg, P
Lycke, J
Malmestrom, C
Ekholm, S
Bergstrom, T
Svennerholm, B
Andersen, O
机构：
来源：
NEUROLOGY | 2001年 / 56卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：A74 / A74
页数：1
相关论文
共 50 条
  • [1] A double-blind, placebo-controlled, randomized trial of cladribine in relapsing-remitting multiple sclerosis
    Romine, JS
    Sipe, JC
    Koziol, JA
    Zyroff, J
    Beutler, E
    [J]. PROCEEDINGS OF THE ASSOCIATION OF AMERICAN PHYSICIANS, 1999, 111 (01) : 35 - 44
  • [2] Acyclovir treatment of relapsing-remitting multiple sclerosis - A randomized, placebo-controlled, double-blind study
    Lycke, J
    Svennerholm, B
    Hjelmquist, E
    Frisen, L
    Badr, G
    Andersson, M
    Vahlne, A
    Andersen, O
    [J]. JOURNAL OF NEUROLOGY, 1996, 243 (03) : 214 - 224
  • [3] Probiotic supplementation and systemic inflammation in relapsing-remitting multiple sclerosis: A randomized, double-blind, placebo-controlled trial
    Rahimlou, Mehran
    Nematollahi, Shima
    Husain, Durdana
    Banaei-Jahromi, Nasrin
    Majdinasab, Nastaran
    Hosseini, Seyed Ahmad
    [J]. FRONTIERS IN NEUROSCIENCE, 2022, 16
  • [4] Efficacy and Safety of Tabalumab in Patients with Relapsing-Remitting Multiple Sclerosis: A Randomized, Double-Blind, Placebo-Controlled Study
    Silk, Maria
    Nantz, Eric
    [J]. NEUROLOGY, 2018, 90
  • [5] The effects of ginger supplementation on common gastrointestinal symptoms in patients with relapsing-remitting multiple sclerosis: a double-blind randomized placebo-controlled trial
    Foshati, Sahar
    Poursadeghfard, Maryam
    Heidari, Zahra
    Amani, Reza
    [J]. BMC COMPLEMENTARY MEDICINE AND THERAPIES, 2023, 23 (01)
  • [6] The effects of ginger supplementation on common gastrointestinal symptoms in patients with relapsing-remitting multiple sclerosis: a double-blind randomized placebo-controlled trial
    Sahar Foshati
    Maryam Poursadeghfard
    Zahra Heidari
    Reza Amani
    [J]. BMC Complementary Medicine and Therapies, 23
  • [7] A randomized double-blind placebo-controlled trial of low-dose interleukin-2 in relapsing-remitting multiple sclerosis
    Louapre, C.
    Rosenzwajg, M.
    Golse, M.
    Roux, A.
    Pitoiset, F.
    Adda, L.
    Tchitchek, N.
    Papeix, C.
    Maillart, E.
    Ungureanu, A.
    Charbonnier-Beaupel, F.
    Galanaud, D.
    Corvol, J. C.
    Vicaut, E.
    Lubetzki, C.
    Klatzmann, D.
    [J]. JOURNAL OF NEUROLOGY, 2023, 270 (09) : 4403 - 4414
  • [8] A double-blind, placebo-controlled, multicentre study to evaluate dirucotide in relapsing-remitting multiple sclerosis
    Selmaj, K.
    Verco, T.
    Ossanna, M.
    Nilsson, M.
    Ferenczi, L.
    Chappell, A.
    Arfors, L.
    [J]. MULTIPLE SCLEROSIS, 2009, 15 (09): : S235 - S235
  • [9] Epigallocatechin Gallate in Relapsing-Remitting Multiple Sclerosis A Randomized, Placebo-Controlled Trial
    Bellmann-Strobl, Judith
    Paul, Friedemann
    Wuerfel, Jens
    Doerr, Jan
    Infante-Duarte, Carmen
    Heidrich, Elmira
    Koertgen, Benedict
    Brandt, Alexander
    Pfuller, Caspar
    Radbruch, Helena
    Rust, Rebekka
    Siffrin, Volker
    Aktas, Orhan
    Heesen, Christoph
    Faiss, Juergen
    Hoffmann, Frank
    Lorenz, Mario
    Zimmermann, Benno
    Groppa, Sergiu
    Wernecke, Klaus-Dieter
    Zipp, Frauke
    [J]. NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2021, 8 (03):
  • [10] A Double-Blind, Randomized, Placebo-Controlled Trial of Simvastatin as Add-On Therapy to Interferon-Beta-1a for the Treatment of Relapsing-Remitting Multiple Sclerosis
    Sorensen, Per Soelberg
    Lycke, Jan
    Eralinna, Juha-Pekka
    Edland, Astrid
    Wu, Xingchen
    Frederiksen, Jette L.
    Oturai, Annette Bang
    Malmestrom, Clas
    Stenager, Egon
    Sperling, Bjorn
    [J]. NEUROLOGY, 2011, 76 (09) : A546 - A547
12345